Trial Profile
A prospective, active-controlled, parallel group study to identify the superiority of oral gliptins and metformin compared to metformin monotherapy in lipid profile correction in newly diagnosed, treatment-naive type 2 diabetes mellitus patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Sitagliptin (Primary) ; Metformin
- Indications Dyslipidaemias; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 25 Jun 2018 New trial record